Pharmacokinetics and ecodisposition of polyhalogenated hydrocarbons: aspects and concepts

Kinetic assessment of persistent halogenated xenobiotics in cell culture models: comparison of mono- and poly-halogenated compounds

We evaluated the suitability of single and multiple cell type cultures as model systems to characterise cellular kinetics of highly lipophilic compounds with potential ecotoxicological impact. Confluent mono-layers of human skin fibroblasts, rat astrocytoma C6 cells, non-differentiated and differentiated mouse 3T3 cells were kept in culture medium supplemented with 10% foetal calf serum. For competitive uptake experiments up to four different cell types, grown on glass sectors, were exposed for 3h to (14)C-labelled model compounds, dissolved either in organic solvents or incorporated into unilamellar lecithin liposomes. Bromo-, or chloro-benzenes, decabromodiphenylether (DBP), and dichlorodiphenyl ethylene (DDE) were tested in rather high concentration of 20 microM. Cellular toxicity was low. Compound levels were related to protein, DNA, and triglyceride contents. Cellular uptake was fast and dependent on physico-chemical properties of the compounds (lipophilicity, molecular size), formulation, and cell type. Mono-halogenated benzenes showed low and similar uptake levels (=low accumulation compounds). DBP and DDE showed much higher cellular accumulations (=high accumulation compounds) except for DBP in 3T3 cells. Uptake from liposomal formulations was mostly higher than if compounds were dissolved in organic solvents. The extent of uptake correlated with the cellular content of triglycerides, except for DBP. Uptake competition between different cell types was studied in a sectorial multi-cell culture model. For low accumulation compounds negligible differences were found among C6 cells and fibroblasts. Uptake of DDE was slightly and that of DBP highly increased in fibroblasts. Well-defined cell culture systems, especially the sectorial model, are appropriate to screen for bioaccumulation and cytotoxicity of (unknown) chemical entities in vitro.

The use of 2,4,5,2',4',5'-hexachlorobiphenyl (6-CB) as an unmetabolizable lipophilic model compound

2,4,5,2',4'5'-Hexachlorobiphenyl (6-CB)--a polychlorinated biphenyl (PCB) congener resistant to metabolism in most species--has become a major residue in the biosphere including human adipose tissue. Its use as a model of unmetabolizable lipophilic compounds and as a tool in toxicokinetics in the last two decades is reviewed. This extremely water-insoluble compound is transported in plasma by albumin and lipoproteins. Binding to these plasma proteins appears to be important for uptake and release processes in different tissues. The redistribution kinetics of 6-CB as well as its pronounced adipose tissue storage and a very slow excretion with the faeces has been established in long-term animal studies. Excretion is strongly influenced by an increasing or diminishing adipose storage compartment size. Other minor pathways of elimination, e.g., via hair, become also important in the absence of metabolism and renal excretion. 6-CB has revealed the possibility of an almost quantitative transfer of the maternal body burden to the offspring via milk. The use of 6-CB in studies with tissue preparations in vitro is providing insight into transport mechanisms of uptake and release.

Kinetics of distribution and elimination of DDE in rats

1. Rats were given single i.v. doses of 14C-DDE, and total drug (14C) and unchanged DDE (g.l.c.) were measured for up to 14 days in blood, tissues, and excreta. The 14C recoveries amounted to 90.0 +/- 10.8 (SD) % dose. 2. DDE underwent redistribution from blood to liver, muscle, skin and, ultimately, adipose tissue. The tissue/blood concentration ratios were 6 for liver and muscle, 35 for skin, 400 for adipose tissue. Concentrations in blood and lean tissues declined biphasically with beta-half-lives of 8-12 days. The half-lives for adipose tissue and total body burden were larger by one order of magnitude. However, due to the increase of adipose tissue mass with time, the amount of DDE stored therein remained constant at almost 60% dose. 3. Except for liver, no substantial metabolite concentrations in tissues were found. In particular, lipophilic metabolites were clearly absent. Thus, tissue kinetics and storage are controlled by unchanged DDE. 4. Of a given dose of DDE, 31% was excreted in the faeces as polar metabolites within 14 days, and 3-4% dose as DDE. Urinary excretion was negligible. The beta-half-life of faecal excretion was equal to the one in blood and lean tissues. It is concluded that excretion is limited by the slow formation of polar metabolites of DDE.

The effect of diet and litter size on the elimination of 2,4,5,2',4',5'-[14C]hexachlorobiphenyl from lactating mice

It was shown that 2,4,5,2',4',5'-hexachlorobiphenyl (6-CB) administered to adult female mice accumulated in their nursing offspring more rapidly than a dose administered to weanling mice when treated animals were bred at equivalent ages. This suggested that the PCB was eliminated from the maternal animal relative to its time of sequestration into storage depots. Using a model which more closely approximates conditions during human lactation, the influence of a high-fat diet and decreased litter size on this phenomenon was examined. Female ICR mice were treated with 4 mg/kg [14C]-6-CB as 13-g weanlings (dW) at 3 weeks of age or as adults (dA) at 11 weeks of age. All animals were mated at 11 weeks of age. On Day 1 of pregnancy, mice were placed on a low-fat (11.5% of the total calories) or high-fat (43.8% of total calories) diet. At parturition, litters were adjusted to either two or eight within each diet group. Elimination of maternal 6-CB was determined by assessing radioactivity in offspring carcasses on Day 15 of gestation or Day 1, 3, 5, 10, or 15 postpartum. Consumption of a high-fat diet significantly extended the t1/2 of elimination of 6-CB from mothers nursing a litter of two in the dW group (low fat = 7.3 days; high fat = 12.4 days) and in both the dW and dA groups nursing litters of eight (dW: low fat = 4.6 days; high fat = 6.8 days; and dA: low fat = 1.8 days; high fat = 3.0 days). Within diet and group, reducing litter size to two also significantly decreased the rate of elimination of 6-CB from maternal animals. 6-CB was eliminated to offspring more rapidly from the dA group when compared to the dW group regardless of diet in animals nursing litters of eight. This relationship was not observed in maternal animals nursing litters of two. In general, exposure to a high-fat diet increased the t1/2 of elimination of 6-CB from maternal animals. Reducing litter size had a greater influence and also masked the ordered mobilization of 6-CB relative to its time of sequestration. Thus, under experimental conditions which more closely mimic the human situation, 6-CB was eliminated less rapidly in the rodent, and sequential 6-CB doses were equally available to nursing offspring.

What can the use of unmetabolizable lipophilic compounds tell about the importance of drug metabolism?

6-CB, a model compound which because of its lipophilicity cannot be excreted by the kidneys and is also unmetabolizable, shows an extreme type of pharmacokinetics. In rats given single doses the compound disappears with a half-life of half a life span by fecal excretion. If adipose tissue mass is allowed to increase, the 75% dose initially stored in adipose tissue does not decrease during 280 days. With repeated weekly administration each dose adds some 90% to the body burden. It is concluded that the old hypothesis of drug-metabolizing enzymes as a protective system preventing accumulation of naturally occurring lipophilic drugs is correct.

[Concentration of polychlorobiphenyl in the population of Greater São Paulo, Brazil]

Os policloretos de bifenila (PCBs), cuja utilização iniciou-se em 1930 em sistemas fechados (capacitores e transformadores elétricos) foram observados no ambiente em 1966, atingindo a cadeia alimentar e acumulando-se no tecido subcutâneo de seres humanos; ao mesmo tempo, foi possível mostrar que esses produtos químicos são potencialmente nocivos para a saúde humana. Como em 1976 os PCBs foram encontrados no tecido gorduroso de pequena amostra da população brasileira, decidiu-se fazer um estudo mais amplo, analisando-se por cromatografia de fase gasosa a gordura do tecido celular subcutâneo de 189 pessoas, de ambos os sexos, que tinham sofrido morte violenta. Foram encontrados níveis médios de 0,8661 ppm em indivíduos do sexo masculino, que apresentaram aumento linear das concentrações de acordo com a idade, o que não foi observado entre os do sexo feminino, onde os valores médios de acúmulo foram de 1,4530 ppm. Do total de amostras, 12,7% apresentaram níveis superiores a 1,95 ppm. É discutida a importância do achado e são assinaladas as medidas de proteção da população brasileira exposta aos PCBs.

Temporal effects on antipyrine metabolite kinetics in Aroclor 1254-treated rats

The in vivo consequences of a single dose of Aroclor 1254 (50 mg/kg) on the drug metabolizing capacity of rats were investigated. A noninvasive method, employing [N-methyl-14C]-antipyrine where both 14CO2 exhalation and urinary excretion of 4-hydroxy-, 3-hydroxymethyl-, and norantipyrine were monitored, was used. A group of rats were sequentially tested over a 3-week period to characterize temporal patterns. The antipyrine metabolite kinetic approach demonstrated that induction of hepatic cytochrome P-450 is maximal 3-6 days after Aroclor 1254 administration and the effects were apparent for at least a further 14-17 days. Evidence is presented to suggest selective effects of Aroclor 1254 on different cytochromes P-450 are apparent in vivo.

Pharmacokinetics in rats of 2,4,5,2',4',5'-hexachlorobiphenyl, an unmetabolizable lipophilic model compound

1. Pharmacokinetics of the unmetabolizable lipophilic model compound, 2,4,5,2',4',5'-hexachlorobiphenyl (6-CB) was studied in rats, using g.l.c. and 14C methods. 2. After single i.v. doses of 0.6 and 3.6 mg/kg, 16% dose was excreted in 40 weeks in the faeces; the value for infinite time was 17% dose. This limited excretion was first-order with a half-life of 100 days for the terminal component. Urinary excretion was nearly complete after 1 week and amounted to 0.8% dose. 3. 6-CB was redistributed from blood to liver, muscle, skin, and adipose tissue. The latter contained a constant level of about 75% dose from 6 to 40 weeks, while the total lean tissue level fell to 6% dose; only 6-CB in the lean tissue compartment was available for excretion. 4. In rats given six oral doses of 0.6 mg/kg at weekly intervals, excretion and distribution patterns were similar to the single-dose situation, and were thus independent of dose, route of administration, and dose regimen. 5. It is concluded that in rats under physiological conditions, about 75% of every dose of 6-CB is irreversibly stored in adipose tissue and that excretion is limited to 18% dose. 6-CB in rats exhibit novel pharmacokinetics of unmetabolizable lipophilic compounds.